Empiric Quinidine for Asymptomatic Brugada Syndrome
Status:
Withdrawn
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if quinidine therapy (not guided by the results of
electrophysiologic studies) will reduce the long-term risk of arrhythmic events in
asymptomatic Brugada Syndrome.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
International Registry of Asymptomatic Brugada Syndrome